AG003RGT

71125-38-7 | 4-hydroxy-2-methyl-N-(5-methyl-1,3-thiazol-2-yl)-1,1-dioxo-2H-1$l^{6},2-benzothiazine-3-carboxamide

AG003RGT

SDS

COA

Price

$0.00

Add to Cart

Buy Now

WARNING This product is not for human or veterinary use.

CAS Number	71125-38-7
Catalog Number	AG003RGT(AGN-PC-0TYOJQ)
Chemical Name	4-hydroxy-2-methyl-N-(5-methyl-1,3-thiazol-2-yl)-1,1-dioxo-2H-1$l^{6},2-benzothiazine-3-carboxamide
EC Number	615-253-8
IUPAC Name	4-hydroxy-2-methyl-N-(5-methyl-1,3-thiazol-2-yl)-1,1-dioxo-1λ6,2-benzothiazine-3-carboxamide
InChI	InChI=1S/C14H13N3O4S2/c1-8-7-15-14(22-8)16-13(19)11-12(18)9-5-3-4-6-10(9)23(20,21)17(11)2/h3-7,18H,1-2H3,(H,15,16,19)
InChI Key	ZRVUJXDFFKFLMG-UHFFFAOYSA-N
MDL Number	MFCD00868752
Molecular Formula	C14H13N3O4S2
Molecular Weight	351.4007
SMILES	O=C(C1=C(O)C2=CC=CC=C2S(N1C)(=O)=O)NC3=NC=C(C)S3
UNII	VG2QF83CGL
Synonyms	Masflex, meloxicam, miloxicam, Mobec, Mobic, Mobicox, Movalis, Movicox, Parocin, reumoxicam, Uticox, meloxicam, 71125-38-7, Mobic, Metacam, Movalis, Mobicox, Meloxicam (Mobic), Mobec, Meloxicamum, Movatec, Parocin, Meloxicamum [Latin], UH-AC 62XX, 4-hydroxy-2-methyl-N-(5-methyl-1,3-thiazol-2-yl)-2H-1,2-benzothiazine-3-carboxamide 1,1-dioxide, 4-Hydroxy-2-methyl-N-(5-methylthiazol-2-yl)-2H-benzo[e][1,2]thiazine-3-carboxamide 1,1-dioxide, UNII-VG2QF83CGL, Tenaron, UHAC-62XX, CCRIS 9139, C14H13N3O4S2, 4-Hydroxy-2-methyl-N-(5-methyl-2-thiazolyl)-2H-1,2-benzothiazine-3-carboxamide 1,1-dioxide, VG2QF83CGL, CHEMBL599, MLS000028587, CHEBI:6741, MFCD00868752, miloxicam, NCGC00018248-04, AK-77454, SMR000058994, DSSTox_CID_803, Meloxicam, 99-101%, 4-hydroxy-2-methyl-N-(5-methyl-2-thiazolyl)-2H-1,2-benzothiazine-3-carboxamide-1,1-dioxide, DSSTox_RID_75796, DSSTox_GSID_20803, Revmoksikam, Coxflam, Coxicam, Melonex, Meloxivet, Vivlodex, 2H-1,2-Benzothiazine-3-carboxamide, 4-hydroxy-2-methyl-N-(5-methylthiazolyl)-, 1,1-dioxide, 4-Hydroxy-2-methyl-N-(5-methyl-2-thiazoyl)-2H-1,2-benzothiazine-3-carboxamide-1,1-dioxide, (E)-3-(hydroxy((5-methylthiazol-2-yl)amino)methylene)-2-methyl-2,3-dihydro-4H-benzo[e][1,2]thiazin-4-one 1,1-dioxide, CAS-71125-38-7, Ratio-meloxicam, Apo-meloxicam, Dom-meloxicam, Gen-meloxicam, Novo-meloxicam, Co Meloxicam, PHL-meloxicam, PMS-meloxicam, HSDB 7741, Meloxicam(Mobic), Meloxicam [USAN:USP:INN:BAN], Meloxicam,(S), 4-hydroxy-2-methyl-N-(5-methyl-1,3-thiazol-2-yl)-1,1-dioxo-1?^{6},2-benzothiazine-3-carboxamide, MXM, Mobic (TN), Opera_ID_2, AC1NTUST, Spectrum_001633, AC1Q3XZW, Spectrum2_000941, Spectrum3_000649, Spectrum4_000787, Spectrum5_001813, AC1L1HB1, AC1NQY12, SCHEMBL3576, Lopac0_000766, SCHEMBL33369, BSPBio_002257, KBioGR_001234, KBioSS_002113, Meloxicam (JAN/USAN/INN), Meloxicam [USAN:BAN:INN], MLS001304725, MLS001306413, MLS006011422, BIDD:GT0726, SCHEMBL713100, SPECTRUM1504150, SPBio_000902, GTPL7220, CHEMBL1741042, DTXSID1020803, CTK6C3599, CTK6C3600, KBio2_002113, KBio2_004681, KBio2_007249, KBio3_001477, ETI-511, ZRVUJXDFFKFLMG-UHFFFAOYSA-N, HMS1922D19, HMS2089B18, HMS2096I19, HMS2234P07, HMS2236C09, HMS3259H06, HMS3372C13, HMS3372P18, HMS3655K06, HMS3713I19, ALBB-027268, BB_SC-04648, BCP11928, HY-B0261, KS-00000JN4, ZX-AN025777, Tox21_111734, Tox21_113192, Tox21_201689, Tox21_302756, ANW-57553, BBL029076, BDBM50056998, BG0248, CCG-39098, HSCI1_000045, s1734, STK620505, ZINC13129998, AKOS000279442, AKOS026749959, Tox21_111734_1, ZINC103620661, AC-1325, CS-2247, DB00814, KS-1084, MCULE-4138373089, NC00698, RTR-031220, SMP2_000133, NCGC00018248-01, NCGC00018248-02, NCGC00018248-03, NCGC00018248-05, NCGC00018248-06, NCGC00018248-07, NCGC00018248-08, NCGC00022924-03, NCGC00022924-04, NCGC00256316-01, NCGC00259238-01, NCGC00263878-02, 2H-1,2-Benzothiazine-3-carboxamide, 4-hydroxy-2-methyl-N-(5-methyl-2-thiazolyl)-, 1,1-dioxide, AJ-63405, AN-15016, BC200593, CC-30198, CPD000718800, LS-40538, SAM002589991, SC-12165, SMR000718800, AB0007297, AB1009494, Meloxicam 1.0 mg/ml in Dimethyl Sulfoxide, TL8005001, FT-0082769, FT-0628193, M1959, R3928, ST24023559, SW219562-1, EN300-52507, C08169, D00969, J10218, N-1539, AB00383033-17, AB00383033-18, AB00383033_20, 125M387, A837087, AN-668/13244001, C-20653, I06-0490, SR-01000003132-10, F2173-0387, Z1695493323, (3E)-3-[hydroxy-[(5-methyl-1,3-thiazol-2-yl)amino]methylidene]-2-methyl-1,1-dioxo-1, (3Z)-3-[hydroxy-[(5-methyl-1,3-thiazol-2-yl)amino]methylidene]-2-methyl-1,1-dioxo-1, 3-[hydroxy-[(5-methyl-1,3-thiazol-2-yl)amino]methylidene]-2-methyl-1,1-dioxo-1, 4-hydroxy-2-methyl-N-(5-methy-2-thiazolyl)-2H-1,2-benzothiazine-3-caboxamide-1,1-dioxide, (3Z)-2-methyl-3-[[(5-methyl-1,3-thiazol-2-yl)amino]-oxidanyl-methylidene]-1,1-bis(oxidanylidene)-1$l^{6},2-benzothiazin-4-one, (3Z)-3-[hydroxy-[(5-methyl-2-thiazolyl)amino]methylidene]-2-methyl-1,1-dioxo-1$l^{6},2-benzothiazin-4-one, 1027136-06-6, 133687-22-6, 3-[hydroxy-[(5-methylthiazol-2-yl)amino]methylene]-2-methyl-1,1-dioxo-1$l^{6},2-benzothiazin-4-one, 3-{hydroxy[(5-methyl-1,3-thiazol-2-yl)amino]methylidene}-2-methyl-2,3-dihydro-4H-1,2-benzothiazin-4-one 1,1-dioxide, 4-Hydroxy-1,1-dioxo-1,2-dihydro-1lambda*6*-benzo[e][1,2]thiazine-3-carboxylic acid (5-methyl-thiazol-2-yl)-amide, 4-hydroxy-2-mehtyl-N-(5-mehtyl-2-thiazolyl)-2H-1,2-benzothiazine-3-carboxamide 1,1-dioxide, 4-Hydroxy-2-methyl-1,1-dioxo-1,2-dihydro-1lambda*6*-benzo[e][1,2]thiazine-3-carboxylic acid (5-methyl-thiazol-2-yl)-amide, 4-hydroxy-2-methyl-N-(5-methyl-1,3-thiazol-2-yl)-1,1-dioxo-1$l^{6},2-benzothiazine-3-carboxamide, 4-hydroxy-2-methyl-N-(5-methyl-1,3-thiazol-2-yl)-1,1-dioxo-2H-1$l;{6},2-benzothiazine-3-carboxamide, 4-hydroxy-2-methyl-N-(5-methyl-1,3-thiazol-2-yl)-1,1-dioxo-2H-1lambda6,2-benzothiazine-3-carboxamide, 4-Hydroxy-2-methyl-N-(5-methyl-1,3-thiazol-2-yl)-2H-1,2-benzothiazin-3-crboxamide 1,1-dioxide, reumoxicam, Maxicam, Melfax, Meloxicam sodium, Meloxidolor, Meloxoral, Rheumocam, Masflex, Melosus, Movicox, Uticox, Novem, RevitaCAM, Meloxicam 5g, meloxicam sodium hydrate, Meloxicam [BAN:INN], D0G7FJ, Meloxicam [USAN:INN:BAN], Meloxicam (SoluMatrix/arthritis), CID4052, ACN-048198, C14-H13-N3-O4-S2, CID5281106, CID5388987, CS-O-11686, NCGC00159516-02, Meloxicam (SoluMatrix/arthritis), iCeutica, A8466, A10565, C065757, SR-01000003132, D000077239, Meloxicam nanoformulation capsules (arthritis), iCeutica, Meloxicam, 99%, a selective COX inhibitor - 25G 25g, 2H-1,2-Benzothiazine-3-carboximidic acid, 4-hydroxy-2-methyl-N-(5-methyl-2-thiazolyl)-, 1,1-dioxide,

Complexity	628
Compound Is Canonicalized	Yes
Covalently-Bonded Unit Count	1
Defined Atom Stereocenter Count	0
Defined Bond Stereocenter Count	0
Exact Mass	351.035g/mol
Formal Charge	0
Heavy Atom Count	23
Hydrogen Bond Acceptor Count	7
Hydrogen Bond Donor Count	2
Isotope Atom Count	0
Molecular Weight	351.395g/mol
Monoisotopic Mass	351.035g/mol
Rotatable Bond Count	2
Topological Polar Surface Area	136A^2
Undefined Atom Stereocenter Count	0
Undefined Bond Stereocenter Count	0
XLogP3	3

GHS Hazard and Precautionary Statements

Symbol:
Hazard Class	6.1
Hazard statements	H302-H315-H319-H335
Packing Group	Ⅲ
Precautionary statements	P261-P305+P351+P338
UN Code	UN 2811

Certificate of Analysis

Lot Number